Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Post by antigua1987on Mar 18, 2022 9:56am

Let's hope imv's name does not come up

CTV: 'WHO pauses approval of Quebec's Medicago COVID-19 vaccine due to tobacco industry ties' Hello imv risk managament? did anyone look into this connection and evaluate downside? Board ...more  
Post by Biotech010on Mar 17, 2022 8:56am

Capitalize on DPX platform in 2022

On the webcast, which was great with lots of new info, the CEO mentioned right in the beginning, that IMV is going to capitalize on the DPX platform in 2022!   This is the first time that the ...more  
Comment by Biotech010on Mar 14, 2022 3:33pm

RE:RE:prestigious oral presentation spot at AACR

IMV will present an abstract poster at the AACR conference featuring updated interim data with survivin vaccine candidate maveropepimut-S (MVP-S) plus KEYTRUDA with low dose cyclophosphamide (CPA ...more  
Comment by Hideawayon Mar 11, 2022 11:32am

RE:prestigious oral presentation spot at AACR

Biotech,could you re-post Abbot's notes re the oral presentation as it did not come through on your post.
Post by Biotech010on Mar 11, 2022 6:50am

prestigious oral presentation spot at AACR

Nick Abbott at Wells Fargo put out a multi-company note this morning previewing presentations that his companies will make at the AACR conference next month. The AACR conference has replaced ASCO as ...more  
Comment by Jthom376on Mar 08, 2022 8:20pm

RE:Updates

April..AACR though would think they would have EOY earnings. 
Post by Lambomon Mar 08, 2022 8:34am

Updates

Anyone know rough timing for scheduled next update? I think deep down theres some big news on the table but time will tell. I suppose now really is not a good time for them to do a major nr anyways ...more  
Comment by antigua1987on Feb 28, 2022 7:58pm

RE:Today

2hrs+. Lots of tech detail not so much intended for avg investor. But Graff and esp Kalos can talk in plain(ish) language. Key from Kalos: IMV has been doing good work - only needs new eyes to look at ...more  
Post by Lambomon Feb 24, 2022 8:37pm

Today

Did anyone listed today? Anything worthwhile?
Post by antigua1987on Feb 18, 2022 3:43pm

Did anyone catch Andy's utube vid before it disappeared?

Was there maybe a few weeks along with handful of other employee vids. Don't recall any obv faux pas. And eventho looked like he did it himself, it wasn't hostage quality. Must've messed ...more  
Post by Hideawayon Feb 17, 2022 10:09am

PR

IMV to Host a Webcast to Highlight its Immune-Educating DPX® Platform  Download as PDF FEBRUARY 17, 2022 7:05AM EST   Event will feature Michael Kalos, Ph.D., member of IMV ...more  
Post by Hideawayon Feb 11, 2022 11:07am

TRC’s Interview

LR,thanks for the link.This provides a good indication as to our current path forward with lots of examples. Let's hope the Feb. 24tr presentation provides more details as to what IMV's future ...more  
Comment by LR6852on Feb 11, 2022 9:53am

RE:Anyone else hoping MKalos brings it on Feb24?!

https://us5.campaign-archive.com/?e=__test_email__&u=d3a1417c9ff35564e0ddc31e9&id=c47da87871 This interview mentions what may be discussed at the Feb 24th event as well as other interesting ...more  
Post by antigua1987on Feb 10, 2022 12:50pm

Anyone else hoping MKalos brings it on Feb24?!

It feels that exec team changes are producing, for now, a stronger company story: ceo, cso, vpIR trying to rebuild a foundation of confidence. And really expect heavyweights on BoD to shine IMVs light ...more  
Comment by TexasTea20on Feb 09, 2022 7:24pm

RE:RE:RE:RE:Shareprice

Still here. More shares than ever. Nothing to say. This just has to play out.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities